The company, headquartered in Bath, producing cannabis-derived products, plans to launch its own Apple-style retail offering through a series of projects that it hopes will turn it into one of the largest enterprises in the sector.
George Botanicals, licensed to grow hemp at a family farm in Somerset, produces Cannabinoid (CBD) products and is supported by Sativa Investments, a British cannabis investment company.
Along with a retail offer, the company plans to open a £ 12 million greenhouse in the region. The greenhouse will have everything for growing hemp plants and a plant for the extraction and production of cannabidiol. Cannabiodil is a psychoactive substance in cannabis.It is a substance with many therapeutic properties that allows it to be used successfully in the treatment of epilepsy, cramping with multiple sclerosis, anxiety disorders, bipolar mental disorders, schizophrenia, nausea and loss of appetite with chemotherapy, convulsions, inflammation, diabetes, heart disease, and it also inhibits growth cancer cells.
It should be noted that by 2028 the cannabis sector in Europe could cost 8 billion euros.